title: Patient Safety and Methylene Blue-Associated Severe Serotonin Toxicity.
authors.affiliation: David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, hkrosenbaum@mednet.ucla.edu PsychoTropical Research, Bucasia, Queensland, Australia.
authors.forename: Harvey K
authors.initials: HK
authors.lastname: Rosenbaum
authors.forename: P Ken
authors.initials: PK
authors.lastname: Gillman
mesh_terms: D004347:Drug Interactions / Q000502:physiology; D005473:Fluoxetine / Q000009:adverse effects / Q000097:blood; D006801:Humans; D008751:Methylene Blue / Q000009:adverse effects* / Q000378:metabolism; D008995:Monoamine Oxidase / Q000097:blood; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects* / Q000097:blood; D061214:Patient Safety / Q000592:standards; D020230:Serotonin Syndrome / Q000097:blood / Q000139:chemically induced* / Q000175:diagnosis; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000097:blood; D012720:Severity of Illness Index
chemical_list: D005473:Fluoxetine; D008751:Methylene Blue; D008995:Monoamine Oxidase; D008996:Monoamine Oxidase Inhibitors; D017367:Selective Serotonin Reuptake Inhibitors